VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Nagendran on Family History, BRCA Status, and Risk

Sukumar Nagendran, MD
Published: Monday, Jan 20, 2014

Sukumar Nagendran, MD, vice president, medical affairs, Quest Diagnostics, discusses a study looking at patients’ family history, BRCA mutation status, and breast cancer risk.

This study found that patients who have tested negative for BRCA2 but have a strong family history of breast cancer still have an increased risk of breast cancer.

Nagendran wonders if there are other single-nucleotide polymorphisms (SNPs) within family members that have not been identified, if the patients in this study were affected by an environmental factor, and if these patients should have additional screening (such as MRI) of their breast.

Nagendran says further research is needed in this area.
Sukumar Nagendran, MD, vice president, medical affairs, Quest Diagnostics, discusses a study looking at patients’ family history, BRCA mutation status, and breast cancer risk.

This study found that patients who have tested negative for BRCA2 but have a strong family history of breast cancer still have an increased risk of breast cancer.

Nagendran wonders if there are other single-nucleotide polymorphisms (SNPs) within family members that have not been identified, if the patients in this study were affected by an environmental factor, and if these patients should have additional screening (such as MRI) of their breast.

Nagendran says further research is needed in this area.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x